AVEO PHARMACEUTICALS INC·4

Jan 28, 5:51 PM ET

Slichenmyer William 4

4 · AVEO PHARMACEUTICALS INC · Filed Jan 28, 2013

Insider Transaction Report

Form 4
Period: 2013-01-24
Slichenmyer William
Chief Medical Officer
Transactions
  • Award

    Stock Option (right-to-buy)

    2013-01-24+32,50032,500 total
    Exercise: $7.72Exp: 2023-01-24Common Stock (32,500 underlying)
  • Award

    Common Stock

    2013-01-24+37,50061,193 total
  • Sale

    Common Stock

    2013-01-28$7.77/sh1,150$8,93760,043 total
Footnotes (2)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
  • [F2]This option vests in equal monthly installments from January 1, 2013 through January 1, 2017.

Documents

1 file
  • 4
    rrd367812.xmlPrimary

    SLICHENMYER FORM 4